Skip to main content

Quantification of myocardial hypoperfusion with 99m Tc-sestamibi in patients undergoing prolonged coronary artery balloon occlusion.

Publication ,  Journal Article
Persson, E; Palmer, J; Pettersson, J; Warren, SG; Borges-Neto, S; Wagner, GS; Pahlm, O
Published in: Nucl Med Commun
March 2002

Percutaneous transluminal coronary angioplasty provides an excellent opportunity to investigate the location and quantity of hypoperfusion during sudden complete occlusion of one of the major coronary arteries. Thirty-five patients referred for elective percutaneous transluminal coronary angioplasty were injected intravenously with 99mTc-sestamibi during balloon inflation. To visualize and quantify the hypoperfused region, a map of perfusion was constructed from that occlusion study and from the control study performed on the following day. Patients were divided into groups according to proximal or distal occlusion within each of the three coronary arteries. The region of myocardium supplied by each coronary artery varied in location and extended outside the typical borders for all arteries, but most prominently for the left circumflex coronary artery. The quantities of hypoperfusion varied within each artery group, but the average hypoperfusion was greater for the left anterior descending coronary artery than for either the right coronary artery or the left circumflex coronary artery. It is concluded that the quantities of hypoperfusion were highly variable within each artery group. Occlusion of the left anterior descending coronary artery was associated with the largest ischaemic region. The area of hypoperfusion extended outside the typical borders, most prominently for the left circumflex coronary artery.

Duke Scholars

Published In

Nucl Med Commun

DOI

ISSN

0143-3636

Publication Date

March 2002

Volume

23

Issue

3

Start / End Page

219 / 228

Location

England

Related Subject Headings

  • Technetium Tc 99m Sestamibi
  • Sensitivity and Specificity
  • Radiopharmaceuticals
  • Radionuclide Imaging
  • Nuclear Medicine & Medical Imaging
  • Models, Cardiovascular
  • Middle Aged
  • Male
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Persson, E., Palmer, J., Pettersson, J., Warren, S. G., Borges-Neto, S., Wagner, G. S., & Pahlm, O. (2002). Quantification of myocardial hypoperfusion with 99m Tc-sestamibi in patients undergoing prolonged coronary artery balloon occlusion. Nucl Med Commun, 23(3), 219–228. https://doi.org/10.1097/00006231-200203000-00004
Persson, E., J. Palmer, J. Pettersson, S. G. Warren, S. Borges-Neto, G. S. Wagner, and O. Pahlm. “Quantification of myocardial hypoperfusion with 99m Tc-sestamibi in patients undergoing prolonged coronary artery balloon occlusion.Nucl Med Commun 23, no. 3 (March 2002): 219–28. https://doi.org/10.1097/00006231-200203000-00004.
Persson E, Palmer J, Pettersson J, Warren SG, Borges-Neto S, Wagner GS, et al. Quantification of myocardial hypoperfusion with 99m Tc-sestamibi in patients undergoing prolonged coronary artery balloon occlusion. Nucl Med Commun. 2002 Mar;23(3):219–28.
Persson, E., et al. “Quantification of myocardial hypoperfusion with 99m Tc-sestamibi in patients undergoing prolonged coronary artery balloon occlusion.Nucl Med Commun, vol. 23, no. 3, Mar. 2002, pp. 219–28. Pubmed, doi:10.1097/00006231-200203000-00004.
Persson E, Palmer J, Pettersson J, Warren SG, Borges-Neto S, Wagner GS, Pahlm O. Quantification of myocardial hypoperfusion with 99m Tc-sestamibi in patients undergoing prolonged coronary artery balloon occlusion. Nucl Med Commun. 2002 Mar;23(3):219–228.

Published In

Nucl Med Commun

DOI

ISSN

0143-3636

Publication Date

March 2002

Volume

23

Issue

3

Start / End Page

219 / 228

Location

England

Related Subject Headings

  • Technetium Tc 99m Sestamibi
  • Sensitivity and Specificity
  • Radiopharmaceuticals
  • Radionuclide Imaging
  • Nuclear Medicine & Medical Imaging
  • Models, Cardiovascular
  • Middle Aged
  • Male
  • Humans
  • Female